Table 1 Baseline clinical characteristics by BMI and DM status
Variables |  | DM(n = 603) |  | Non-DM(n = 1315) |  | ||
|---|---|---|---|---|---|---|---|
Overall (n = 1918) | Normal-weight (n = 244) | Overweight and Obesity (n = 359) | P value | Normal-weight (n = 599) | Overweight and Obesity (n = 716) | P value | |
Age, y | 60.3(11.3) | 65.0(10.0) | 60.7(10.9) |  < 0.001 | 61.3(11.1) | 57.5(11.5) |  < 0.001 |
Men, No. (%) | 1462 (76.2) | 151 (61.9) | 264 (73.5) | 0.003 | 459 (76.6) | 588(82.1) | 0.017 |
Clinical presentation, No. (%) | |||||||
 CCS | 142 (7.4) | 18 (7.4) | 34 (9.5) | 0.453 | 35 (5.8) | 55 (7.7) | 0.228 |
 UA | 869 (45.3) | 113 (46.3) | 165 (46.0) | 0.999 | 262 (43.7) | 329(45.9) | 0.455 |
 STEMI | 644 (33.6) | 77 (31.6) | 104 (29.0) | 0.555 | 215 (35.9) | 248(34.6) | 0.677 |
 NSTEMI | 263 (13.7) | 36 (14.8) | 56 (15.6) | 0.867 | 87 (14.5) | 84 (11.7) | 0.156 |
Concomitant disease, No. (%) | |||||||
 Hypertension | 1047 (54.6) | 138 (56.6) | 222 (61.8) | 0.225 | 287 (47.9) | 400(55.9) | 0.005 |
 Hyperlipidemia | 381 (19.9) | 46 (18.9) | 68 (18.9) | 1 | 124 (20.7) | 143(20.0) | 0.796 |
 Stroke | 242 (12.6) | 32 (13.1) | 56 (15.6) | 0.465 | 70 (11.7) | 84 (11.7) | 1 |
 RI | 152(7.9) | 32(13.1) | 38(10.6) | 0.411 | 46(7.7) | 36(5.0) | 0.062 |
 PVD | 111 (5.8) | 24 (9.8) | 17 (4.7) | 0.023 | 38 (6.3) | 32 (4.5) | 0.166 |
 CCI | 1.36 (1.05) | 2.16 (1.03) | 2.07 (0.96) | 0.273 | 1.07 (0.91) | 0.98(0.87) | 0.088 |
Smoking status, No. (%) | |||||||
 Never | 1104 (57.6) | 162 (66.4) | 222 (61.8) | 0.521 | 354 (59.1) | 366(51.1) | 0.001 |
 Former smoker | 352 (18.4) | 41(16.8) | 68 (18.9) | 114 (19.0) | 129(18.0) | ||
 Current smoker | 462 (24.1) | 41(16.8) | 69 (19.2) | 131 (21.9) | 221(30.9) | ||
Clinical history, No. (%) | |||||||
 Previous MI | 149 (7.8) | 16 (6.6) | 33 (9.2) | 0.312 | 46 (7.7) | 54 (7.5) | 1 |
 Previous PCI | 87 (4.5) | 10 (4.1) | 24 (6.7) | 0.241 | 30 (5.0) | 23 (3.2) | 0.131 |
 Previous CABG | 23 (1.2) | 1 (0.4) | 3 (0.8) | 0.904 | 7 (1.2) | 12 (1.7) | 0.592 |
Laboratory and Echocardiogram | |||||||
 ALT, IU/L | 32.76(29.47) | 29.91(29.83) | 29.74(25.40) | 0.939 | 31.76(32.20) | 36.28(28.79) | 0.007 |
 ALB, g/L | 40.82(3.80) | 40.06 (4.25) | 40.93(3.88) | 0.01 | 40.44(3.87) | 41.38(3.49) |  < 0.001 |
 Cr, mmol/L | 81.32(54.69) | 84.67(73.67) | 84.26(68.04) | 0.944 | 79.45(44.49) | 80.29(46.84) | 0.739 |
 TG, mmol/L | 1.61 (0.94) | 1.62 (0.90) | 1.80 (1.13) | 0.038 | 1.39 (0.74) | 1.70(0.97) |  < 0.001 |
 TC, mmol/L | 4.27 (1.06) | 4.28 (1.10) | 4.21 (1.06) | 0.466 | 4.21 (1.02) | 4.28(1.05) | 0.237 |
 HDL-C, mmol/L | 1.05 (0.27) | 1.06 (0.27) | 0.99 (0.24) | 0.001 | 1.10 (0.29) | 1.02(0.26) |  < 0.001 |
 LDL-C, mmol/L | 2.59 (0.89) | 2.54 (0.92) | 2.54 (0.88) | 0.965 | 2.55 (0.88) | 2.61(0.84) | 0.248 |
 EF, % | 55.72(8.53) | 55.36 (8.91) | 55.06(8.70) | 0.683 | 55.38(8.89) | 56.35(8.06) | 0.039 |
Discharge prescription, No. (%) | |||||||
 Aspirin | 1910 (99.6) | 243 (99.6) | 358 (99.7) | 1 | 595 (99.3) | 714 (99.7) | 0.529 |
 Clopidogrel | 1878 (97.9) | 242 (99.2) | 353 (98.3) | 0.593 | 587 (98.0) | 696 (97.2) | 0.456 |
 Ticagrelor | 39 (2.0) | 2 (0.8) | 6 (1.7) | 0.593 | 11 (1.8) | 20 (2.8) | 0.339 |
 Statin | 1896 (98.9) | 243 (99.6) | 354 (98.6) | 0.438 | 588 (98.2) | 711 (99.3) | 0.105 |
 Beta-blocker | 1526 (79.6) | 192 (78.7) | 285 (79.4) | 0.916 | 467 (78.0) | 582 (81.3) | 0.154 |
 ACEI/ARB | 1077 (56.2) | 142 (58.2) | 231 (64.3) | 0.15 | 306 (51.1) | 398 (55.6) | 0.115 |
 Oral anti-diabetic drugs | 428 (71.0) | 162 (66.4) | 266 (74.1) | 0.051 | - | - | - |
 Insulin therapy | 264 (43.8) | 121 (49.6) | 143 (39.8) | 0.022 | - | - | - |